Pharma/fine chemicals roundup—26 February

Informex 2013: Bright outlook for US API manufacturing Drug companies looking for speedy turnaround and strong intellectual property (IP) protection for active pharmaceutical ingredient (API) production are moving away from low-cost emerging market firms, lifting prospects for US-based producers, according to attendees of Informex, at Anaheim, CA, last week. Executives said they are seeing more situations where clients feel as though the risk level to bringing the final stages of API production to Asia is too high and are bringing later-phase activities back to...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers